Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings

Am J Cardiol. 1996 May 1;77(11):1004-8. doi: 10.1016/s0002-9149(97)89159-x.

Abstract

Reverse use dependence of action potential duration and effective refractory period by chronic oral sotalol was demonstrated by monophasic action potential recordings in the human ventricle. There were no changes of the QRS duration over the cycle length, indicating that sotalol had no sodium channel blocking effects.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Adolescent
  • Adult
  • Aged
  • Anti-Arrhythmia Agents / pharmacology*
  • Anti-Arrhythmia Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Female
  • Heart Conduction System / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Sotalol / pharmacology*
  • Sotalol / therapeutic use
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / physiopathology
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / physiopathology
  • Ventricular Function / drug effects*

Substances

  • Anti-Arrhythmia Agents
  • Sotalol